
Angie You
Founder/CEO,
Architect Therapeutics
Architect Therapeutics
Location: San Francisco Bay Area
Member Since: 2020
Angie is currently the founder/CEO of Architect Therapeutics. She also serves on the board of Oric Pharmaceuticals and Attovia Therapeutics. Angie was most recently CEO of Amunix Pharmaceuticals, which was acquired in 2021 by Sanofi. She has been involved in multiple companies that have brought meaningful drugs to patients. Prior to Amunix, he served as the CBO at Sierra Oncology (acquired by GSK 2021, Sierra’s drug Ojjara approved 2023 for high risk myelofibrosis) and Aragon Pharmaceuticals (acquired by Janssen 2014, Aragon’s prostate cancer drug Erleada approved 2018). She is a scientist by training with a PhD in Biochemistry from Harvard University. She is a co-founder of the Biotech CEO Sisterhood, a community of female CEOs focused on supporting female executives and increasing representation of female CEOs in the industry. She is also a co-founder/board member of ElevAAte, a non-profit focused on advancing East Asian representation at senior levels across the bio and pharma industry.
